PDF Archive search engine
Last database update: 17 December at 11:24 - Around 76000 files indexed.

Show results per page

Results for «chemotherapy»:

Total: 80 results - 0.023 seconds

Chemo 100%

549e560 doi:10.1016/j.clon.2004.06.007 Overview The Contribution of Cytotoxic Chemotherapy to 5-year Survival in Adult Malignancies Graeme Morgan*, Robyn Wardy, Michael Bartonz *Department of Radiation Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, NSW;


hsporen仁 96%

Journal of American Medical Association (JAMA) Emerging Infectious Diseases (EID) Clinical Infectious Diseases (CID) Journal of Antimicrobial Chemotherapy (JAC) Chest European Journal of Epidemiology Expert Opinion on Pharmacotherapy (EOP) FEMS Immunology &


v15n4S 57Revisiting 94%

In metastatic breast cancer, randomised phase III trials have consistently demonstrated that bevacizumab, when combined with standard first-line chemotherapy regimens, significantly improved response rate and progression-free survival compared with chemotherapy alone.


CV Nobili 90%

in Chemotherapy (University of Milan, Milan).


inhanse bio Andrew Hartley 87%

The effects of synchronous chemotherapy on radiobiological parameters;


813607 JD October2017 (3) 87%

The team provides radiotherapy, chemotherapy and brachytherapy services for the Cancer Centre and linked Units.


31st Consensus Conference 85%

또한, neoadjuvant chemotherapy, intraperitoneal chemotherapy 등의 방법이 기존 항암제 치료 효과를 증가시킬 수 있는지에 대해서도 일시 2017년 5월 20일(토) 9:00 am - 4:00 pm ※만 65세 이상 한국임상암학회, 대한항암요법연구회 회원은 등록비가 면제되오니 등록신청만 해주시기 바랍니다.


Dossier BreastCancerREV 81%

She now faces the physical and emotional effects of having both her breasts surgically removed and the loss of her hair due to chemotherapy.


2016.01.04 08-10-48Reena Nair cv 2016 77%

Phase III trial of BEP chemotherapy versus VIP chemotherapy in testicular germ cell tumours Department Protocol.


The Blood, The Marrow, The Giant Needle 77%

My immune system is confused and and attacks those critical performing cells See, because the doses of chemotherapy &


ESMO-Preceptorship-on-Lung-Cancer-Manchester-2020-Programme.ocr 76%

Giulia Veronesi, IT Cecile Le Pechoux, FR Giulia Veronesi, IT 30’ Stereotactic ablative RT for early stage NSCLC Suresh Senan, NL SESSION 2 Radical treatment of early stage NSCLC 14:40-15:00 Coffee break 30’ Adjuvant radiotherapy for completely resected early stage NSCLC Cecile Le Pechoux, FR 30’ Adjuvant chemotherapy for resected early stage NSCLC Paul Taylor, UK Close of day 1 Chairs:


Hilfreiches bei Krebs 75%

Chlorophyllin Abstract der Studie auf Pubmed:


CTC-Microfluidic-Chip Amir Shahein Loic Chaubet 72%

Evaluating the frequency of both neutrophils and CTCs in blood is of prime importance to chemotherapy patients.


ER1143 72%

Arthur Sun Myint 9.15am Sometimes chemotherapy alone is enough...


26th Consensus Conference 71%

Optimal chemotherapy after curative surgical resection of metastatic colorectal cancer 이명아 (가톨릭의대) 김정호 (서울의대) 40,000원 기타, 업체 참가 50,000원 60,000원 김승태 (성균관의대) 좌장 :


Luca Gianni 70%

    Cancer  Chemotherapy  and  Pharmacology   1994  to  date:



After a bilateral mastectomy, 4.5 months of intensive chemotherapy, and 6 weeks of daily radiation treatments, Darina was ecstatic to announce to everyone that she was cancer-free!


30th Consensus Conference 70%

Ethical Issues in Terminal Care 치료 유보/중단에 대한 윤리적 결정에 대한 지침 김도경 (동아의대) 09:25~09:50 25min 임상윤리 자문의 경험과 팀 접근에 대하여 이명아 (가톨릭의대) 30min What’s New in Management of Chemotherapy induced Nausea and Vomiting 10:20~10:40 20min Coffee Break Session 3 :


07d0c77d5987f908461f9f7c33741941 69%

• Apply Level 1 evidence on the use of chemotherapy in men with newly diagnosed metastatic prostate cancer • Apply Level 1 evidence on the use of active surveillance for men with newly diagnosed low or intermediate risk prostate cancer • Apply level 1 evidence on the optimal approach and sequencing of new agents in the management of advanced renal cancer • Apply level 1 evidence on the optimal approach and sequencing of new agents in the management of advanced bladder cancer • Apply level 1 evidence on the optimal approach and sequencing of new agents in the management of advanced testicular cancer WHO SHOULD ATTEND:


Kasi - Vittal Poster - Final 68%

Efficacy   Progression  free   (in  months)   survival   Overall  Survival   CRYSTAL   (mKRAS)   n=397   FOLFIRI  +   Cetuximab  =  7.4   FOLFOX  +   Panitumumab  =  7.3   FOLFIRI  =  7.5   FOLFOX  alone  –  8.8   PRIME   (mKRAS)   n=440   FOLFIRI  +   Cetuximab  =  16.4   FOLFOX  +   Panitumumab  =  15.5   FOLFIRI  =  17.7   FOLFOX  =  19.3   MRC  COIN   (mBRAF)   n=102   NA   FOLFOX  +Cetuximab     =  7.2     Our  PaPent   1  month   (mKRAS  +  mBRAF)   FOLFOX  =  10   3  months   Discussion CRYSTAL3 and PRIME4 are two most important randomized controlled trials that demonstrated that addition of anti-EGFR drugs to chemotherapy has detrimental outcomes in KRAS mutant mCRC.


sample 81 82 83 67%

Small cell carcinoma (15%)-usually not amenable to surgical resection (treated with chemotherapy) 2.


Abstract 67%

They are also sensitive to EGFR tyrosine kinase inhibitors (TKIs), which provide superior clinical benefits to conventional chemotherapy.



Rotherham NHS Foundation Trust’s Cancer Clinics Referral Guidelines Urgent Referral Proformas (2 week wait) Palliative Care, Chemotherapy, Radiotherapy and Other Specialist Services Support Groups Jan 2016 Directory of Rotherham Cancer Services Including:


29th Consensus Conference 64%

osteosarcoma, ewing sarcoma, rhabdomyosarcoma 최윤라(성균관의대) 13:25 - 13:50 25min Surgical resection of bone sarcoma 김완림(울산의대) 13:50 - 14:15 25min Chemotherapy of osteosarcoma 이수진(성균관의대) 14:15 - 14:40 25min Chemotherapy of ewing's sarcoma/rhabdomyosarcoma 한정우(연세의대) 14:40 - 15:00 20min Coffee Break 재활병원 러들로 교수동 간호대학 연세암병원 현대백화점 50,000원 치과병원 본 관 국민은행 임상의학 연구센터 의과대학(신관) 에비슨 의생명연구센터 치과대학 의학도서관 재활병원 종합관, 장례식장 응급실 동문회관 그랜드마트 2 40,000원 신촌역 창천교회 신촌역(기차) 이화여자대학교 60,000원 사전등록 방법 1.


Doctoral Proposal 63%

2 BACKGROUND AND SIGNIFICANCE Platinum based antineoplastic drugs have been a golden standard in chemotherapy for decades ever since the first of their variety, cisplatin, was shown to increase survival rates for some types of cancers to upwards of 90% compared to just 5% without chemotherapy (1, 2, 3).